# Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast
Canonical URL: https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-third-quarter-conference-call-and-webcast-48419fff
Ticker: AZTA
Company: Azenta Life Sciences
Source: Azenta Life Sciences
Published: 2026-07-22 20:05 EST
Original Source URL: https://investors.azenta.com/2026-07-22-Azenta-Announces-Fiscal-2026-Third-Quarter-Conference-Call-and-Webcast
## Summary

Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2026 earnings which ended on June 30, 2026, on Tuesday, August 4, 2026, after the market closes. The Company will host a conference...

## Article Body
Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast

, / PRNewswire / -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2026 earnings which ended on June 30, 2026, on Tuesday, August 4, 2026, after the market closes.

The Company will host a conference call and live webcast to discuss its financial results the following day, Wednesday, August 5, 2026, at 8:30 a.m. Eastern Time. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events . A replay will be available beginning at 8:30 a.m. ET on August 6, 2026.

About Azenta Life Sciences

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.

Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com .

INVESTOR CONTACTS: Yvonne Perron Vice President, Financial Planning & Analysis, and Investor Relations ir@azenta.com

Maria Isabel Cuartas Manager Investor Relations ir@azenta.com

SOURCE Azenta
## Recent Company News
- 2026-07-22 20:05 EST — [Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast](https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-third-quarter-conference-call-and-webcast-48419fff) — Source: Azenta Life Sciences
- 2026-07-08 12:00 EST — [Azenta Completes Sale of B Medical Systems](https://biopharmsignal.com/news/AZTA/azenta-completes-sale-of-b-medical-systems-869ef834) — Source: Azenta Life Sciences
- 2026-05-21 20:05 EST — [Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report](https://biopharmsignal.com/news/AZTA/azenta-publishes-2025-environmental-social-and-governance-esg-report) — Source: Azenta Life Sciences
- 2026-05-05 20:30 EST — [Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029](https://biopharmsignal.com/news/AZTA/azenta-reports-second-quarter-results-for-fiscal-2026-ended-march-31-2026-updates-full-year-fiscal-2026-guidance-and-extends-long-range-plan-to-2029) — Source: Azenta Life Sciences
- 2026-04-29 20:06 EST — [Azenta Announces Fiscal 2026 Second Quarter Conference Call and Webcast](https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-second-quarter-conference-call-and-webcast) — Source: Azenta Life Sciences
## Related News
- 2026-07-22 20:15 EST — BFRG — [BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-the-btig-virtual-biotechnology-conference-5880a10e)
- 2026-07-22 20:05 EST — VKTX — [Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026](https://biopharmsignal.com/news/VKTX/viking-therapeutics-to-report-financial-results-for-second-quarter-2026-on-july--bbf2553f)
- 2026-07-22 20:01 EST — AXON — [Axon to Release Second Quarter 2026 Earnings on August 5, 2026](https://biopharmsignal.com/news/AXON/axon-to-release-second-quarter-2026-earnings-on-august-5-2026-66120902)
- 2026-07-22 12:39 EST — ARTL — [New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition](https://biopharmsignal.com/news/ARTL/new-analysis-of-over-50-studies-showed-that-all-the-non-prescription-cbd-product-a3445432)
- 2026-07-22 12:30 EST — NRSN — [NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS](https://biopharmsignal.com/news/NRSN/neurosense-advances-primec-toward-new-drug-submission-to-health-canada-for-als-721c198c)